Back to Search
Start Over
Will intestinal flora therapy become a new target in type-2 diabetes mellitus? A review based on 13 clinical trials.
- Source :
-
Nutricion hospitalaria [Nutr Hosp] 2022 Mar 29; Vol. 39 (2), pp. 425-433. - Publication Year :
- 2022
-
Abstract
- Introduction: Background: diabetes mellitus (DM) is a chronic disease and its pathogenesis is still inconclusive. Current evidence suggests an association between intestinal flora and type-2 diabetes mellitus (T2DM). In this paper, we summarized the current research, determining whether intestinal flora may become a new method to treat T2DM, and providing a theoretical basis and literature references for the prevention of T2DM based on the regulation of intestinal flora. Method: we carried out a review based on 13 published clinical trials to determine the correlation between T2DM and intestinal flora, and between changes in clinical outcomes and in intestinal flora in the development of T2DM; to assess the pathological mechanisms; and to discuss the treatment of diabetes based on intestinal flora. Results: we found that intestinal flora is involved in the occurrence and development of T2DM. Several pathological mechanisms may be involved in the process, including improving the gut barrier, alleviating inflammation, increasing glucagon-like peptide (GLP) 1 and GLP 2, increasing the production of short-chain fatty acids (SCFAs), and so on. Several measures based on intestinal flora, including exercise, food, specific diets, drugs and probiotics, would be used to treat and even prevent T2DM. Conclusions: high-quality studies are required to better understand the clinical effects of intestinal flora in T2DM.
Details
- Language :
- English
- ISSN :
- 1699-5198
- Volume :
- 39
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Nutricion hospitalaria
- Publication Type :
- Academic Journal
- Accession number :
- 34844413
- Full Text :
- https://doi.org/10.20960/nh.03866